Blocking the endothelin receptor reduces risk factors for heart disease, the most common cause of death in kidney disease patients….
Read More »Extending Patients’ Lives by Five Years
Adults who engage in at least 150 minutes of moderate to vigorous activity each week can mean living up to five years longer than inactive adults….
Read More »Microaneurysm Turnover Predicts Retinopathy Progression
Automated analysis of microaneurysm (MA) turnover predicted the development of clinically significant macular edema (CSME) among patients with mild nonproliferative diabetic retinopathy (MNDR)….
Read More »Turning Off Carb-to-Fat Conversion
Discovery of a protein involved in the conversion of dietary carbohydrates into fat could have implications down the road for treatment of fatty liver disease, diabetes, and obesity….
Read More »Insulin the Cause of Obesity
Chronically high levels of insulin may be an important underlying cause of obesity….
Read More »Algorithm Used to Detect, Classify Diabetes
Data from electronic health records (EHRs) can be used to detect more cases of diabetes than claim codes alone and can be used to accurately distinguish between type 1 and type 2 diabetes….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #22: Adipose Tissue as an Endocrine Gland
A Possible Key in Understanding the Metabolic Mysteries Osama Hamdy, MD, PhD, FACE (Note to our readers: we inadvertently skipped a number in this series of text excerpts so there was no "Excerpt #21." Our apologies for any confusion, and thanks to the sharp-eyed reader who pointed this out!) The …
Read More »Accountable Care Organizations, Part 2 of 3
In this week’s selection of Homerun Slides, we begin to delve into the details of what Accountable Care Organizations (ACOs) will mean for Medicare and Medicaid beneficiaries, and how the risk-sharing in these new model programs is handled….
Read More »Generic Glucose Test Strips
Generic Glucose Test Strips The first generic test strips for the One Touch and Ultra glucose monitors may soon be available. Decision Diagnostics state on their website that the Shasta Genstrip® "will cost 50% less than the branded product without any sacrifice on quality." The Shasta is not yet approved …
Read More »Statin Users Risk for Diabetes Hinges on Two Factors
Higher-dose atorvastatin (Lipitor) increased the risk of new-onset diabetes compared with lower statin doses, but only among patients who already had at least two risk factors for elevated blood glucose, an analysis of two randomized trials showed….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.